Protein kinase D in vascular biology and angiogenesis

The Protein Kinase D (PKD) family comprises diacylglycerol stimulated serine/threonine protein kinases that participate in many key signaling pathways in a diverse range of cells. Recent studies show that PKD isoforms 1 and 2 play critical roles in vascular biology and angiogenesis and there has been considerable progress in determining some of the key angiogenic signaling pathways mediated by PKD in endothelial cells. Less is currently known regarding the specific roles of PKD isoforms in endothelial cells and the role of PKD in smooth muscle cells. PKD is also emerging as a potentially important mediator of tumor growth and tumor angiogenesis and there is growing interest in PKD as a novel therapeutic target in cancer. © 2011 IUBMB IUBMB Life, 63(4): 258–263, 2011

[1]  Dezheng Zhao,et al.  VEGF stimulates PKD‐mediated CREB‐dependent orphan nuclear receptor Nurr1 expression: Role in VEGF‐induced angiogenesis , 2011, International journal of cancer.

[2]  P. Wipf,et al.  Protein kinase D as a potential new target for cancer therapy. , 2010, Biochimica et biophysica acta.

[3]  Linda V. Sinclair,et al.  Unique functions for protein kinase D1 and protein kinase D2 in mammalian cells , 2010, The Biochemical journal.

[4]  P. Carmeliet,et al.  Protein kinase D2 is a crucial regulator of tumour cell–endothelial cell communication in gastrointestinal tumours , 2010, Gut.

[5]  J. Norman,et al.  Protein Kinase D1 Regulates VEGF‐A‐Induced αvβ3 Integrin Trafficking and Endothelial Cell Migration , 2010, Traffic.

[6]  B. Liu,et al.  Protein kinase Cδ mediates MCP-1 mRNA stabilization in vascular smooth muscle cells , 2010, Molecular and Cellular Biochemistry.

[7]  L. Kèlland,et al.  Characterization of the biological effects of a novel protein kinase D inhibitor in endothelial cells , 2010, The Biochemical journal.

[8]  B. Aggarwal,et al.  A Novel Small-Molecule Inhibitor of Protein Kinase D Blocks Pancreatic Cancer Growth In vitro and In vivo , 2010, Molecular Cancer Therapeutics.

[9]  K. Pfizenmaier,et al.  Protein Kinase D Controls Actin Polymerization and Cell Motility through Phosphorylation of Cortactin* , 2010, The Journal of Biological Chemistry.

[10]  Guanghui Liu,et al.  Hypertrophic response to angiotensin II is mediated by protein kinase D-extracellular signal-regulated kinase 5 pathway in human aortic smooth muscle cells. , 2009, Biochemical and biophysical research communications.

[11]  K. Pfizenmaier,et al.  Protein kinase D regulates cell migration by direct phosphorylation of the cofilin phosphatase slingshot 1 like. , 2009, Cancer research.

[12]  P. Storz,et al.  Protein Kinase D1 regulates Cofilin mediated F-actin reorganization and cell motility via Slingshot , 2009, Nature Cell Biology.

[13]  S. Goodison,et al.  Protein kinase D1 regulates matrix metalloproteinase expression and inhibits breast cancer cell invasion , 2009, Breast Cancer Research.

[14]  S. Steinberg,et al.  Protein Kinase D1 Autophosphorylation via Distinct Mechanisms at Ser744/Ser748 and Ser916* , 2009, Journal of Biological Chemistry.

[15]  Hua Tang,et al.  Identification of Protein Kinase D2 as a Pivotal Regulator of Endothelial Cell Proliferation, Migration, and Angiogenesis* , 2009, Journal of Biological Chemistry.

[16]  L. Reynolds,et al.  Integrins: the keys to unlocking angiogenesis. , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[17]  I. Evans,et al.  Vascular endothelial growth factor induces heat shock protein (HSP) 27 serine 82 phosphorylation and endothelial tubulogenesis via protein kinase D and independent of p38 kinase. , 2008, Cellular signalling.

[18]  E. Olson,et al.  Control of endothelial cell proliferation and migration by VEGF signaling to histone deacetylase 7 , 2008, Proceedings of the National Academy of Sciences.

[19]  E. Olson,et al.  Protein Kinase D-dependent Phosphorylation and Nuclear Export of Histone Deacetylase 5 Mediates Vascular Endothelial Growth Factor-induced Gene Expression and Angiogenesis* , 2008, Journal of Biological Chemistry.

[20]  Shivendra V. Singh,et al.  Protein kinase D3 (PKD3) contributes to prostate cancer cell growth and survival through a PKCepsilon/PKD3 pathway downstream of Akt and ERK 1/2. , 2008, Cancer research.

[21]  I. Evans,et al.  The zinc-finger transcription factor, early growth response 3, mediates VEGF-induced angiogenesis , 2008, Oncogene.

[22]  Mi-Sung Kim,et al.  Requirement of protein kinase D1 for pathological cardiac remodeling , 2008, Proceedings of the National Academy of Sciences.

[23]  F. Dequiedt,et al.  Phosphorylation at Ser244 by CK1 determines nuclear localization and substrate targeting of PKD2 , 2007, The EMBO journal.

[24]  P. Storz,et al.  A Novel Tyrosine Phosphorylation Site in Protein Kinase D Contributes to Oxidative Stress-mediated Activation* , 2007, Journal of Biological Chemistry.

[25]  E. Olson,et al.  Angiotensin II Stimulates Protein Kinase D–Dependent Histone Deacetylase 5 Phosphorylation and Nuclear Export Leading to Vascular Smooth Muscle Cell Hypertrophy , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[26]  K. Pfizenmaier,et al.  PKD is recruited to sites of actin remodelling at the leading edge and negatively regulates cell migration , 2007, FEBS letters.

[27]  U. Moens,et al.  Protein Kinase D Induces Transcription through Direct Phosphorylation of the cAMP-response Element-binding Protein* , 2007, Journal of Biological Chemistry.

[28]  M. Jaggi,et al.  Protein kinase D1: a protein of emerging translational interest. , 2007, Frontiers in bioscience : a journal and virtual library.

[29]  H. Dvorak,et al.  Down Syndrome Candidate Region 1 Isoform 1 Mediates Angiogenesis through the Calcineurin-NFAT Pathway , 2006, Molecular Cancer Research.

[30]  Dezheng Zhao,et al.  Requirement of Protein Kinase D Tyrosine Phosphorylation for VEGF-A165-induced Angiogenesis through Its Interaction and Regulation of Phospholipase Cγ Phosphorylation* , 2006, Journal of Biological Chemistry.

[31]  T. McKinsey,et al.  Protein kinase D directly phosphorylates histone deacetylase 5 via a random sequential kinetic mechanism. , 2006, Archives of biochemistry and biophysics.

[32]  Q. Wang.  PKD at the crossroads of DAG and PKC signaling. , 2006, Trends in pharmacological sciences.

[33]  Z. Jin,et al.  Protein Kinase C-dependent Protein Kinase D Activation Modulates ERK Signal Pathway and Endothelial Cell Proliferation by Vascular Endothelial Growth Factor* , 2005, Journal of Biological Chemistry.

[34]  A. Toker,et al.  A Phosphorylation State-specific Antibody Recognizes Hsp27, a Novel Substrate of Protein Kinase D* , 2005, Journal of Biological Chemistry.

[35]  M. Ohba,et al.  Angiotensin II–Induced Protein Kinase D Activation Is Regulated by Protein Kinase C&dgr; and Mediated via the Angiotensin II Type 1 Receptor in Vascular Smooth Muscle Cells , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[36]  I. Zachary,et al.  Vascular Endothelial Growth Factor–Regulated Gene Expression in Endothelial Cells: KDR-Mediated Induction of Egr3 and the Related Nuclear Receptors Nur77, Nurr1, and Nor1 , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[37]  T. Seufferlein,et al.  Protein kinase D: a family affair , 2003, FEBS letters.

[38]  A. Toker,et al.  Tyrosine Phosphorylation of Protein Kinase D in the Pleckstrin Homology Domain Leads to Activation* , 2003, The Journal of Biological Chemistry.

[39]  W. Ogawa,et al.  Thrombin Rapidly Induces Protein Kinase D Phosphorylation, and Protein Kinase C δ Mediates the Activation* , 2003, The Journal of Biological Chemistry.

[40]  T. Hunter,et al.  The Protein Kinase Complement of the Human Genome , 2002, Science.

[41]  J. Huot,et al.  Integrating the VEGF signals leading to actin-based motility in vascular endothelial cells. , 2000, Trends in cardiovascular medicine.

[42]  P. Storz,et al.  Protein Kinase C μ Is Negatively Regulated by 14-3-3 Signal Transduction Proteins* , 1999, The Journal of Biological Chemistry.

[43]  T. Iglesias,et al.  Identification of in Vivo Phosphorylation Sites Required for Protein Kinase D Activation* , 1998, The Journal of Biological Chemistry.

[44]  A. Toker,et al.  Association of Protein Kinase Cμ with Type II Phosphatidylinositol 4-Kinase and Type I Phosphatidylinositol-4-phosphate 5-Kinase* , 1998, The Journal of Biological Chemistry.

[45]  E. Rozengurt,et al.  Rapid activation of the novel serine/threonine protein kinase, protein kinase D by phorbol esters, angiotensin II and PDGF‐BB in vascular smooth muscle cells , 1998, FEBS letters.

[46]  E. Rozengurt,et al.  Bombesin, Vasopressin, Endothelin, Bradykinin, and Platelet-derived Growth Factor Rapidly Activate Protein Kinase D through a Protein Kinase C-dependent Signal Transduction Pathway* , 1997, The Journal of Biological Chemistry.

[47]  E. Rozengurt,et al.  Protein kinase D (PKD) activation in intact cells through a protein kinase C‐dependent signal transduction pathway. , 1996, The EMBO journal.

[48]  J. Prestle,et al.  PKCu is a novel, atypical member of the protein kinase C family. , 1994, The Journal of biological chemistry.

[49]  A. Arrigo.  The cellular "networking" of mammalian Hsp27 and its functions in the control of protein folding, redox state and apoptosis. , 2007, Advances in experimental medicine and biology.